Protein-Losing Enteropathy in the Failing Fontan: Treatment With Angiotensin Receptor Neprilysin Inhibitor.
Fontan
heart failure
protein-losing enteropathy
sacubitril/valsartan
Journal
JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292
Informations de publication
Date de publication:
17 Jul 2024
17 Jul 2024
Historique:
received:
02
02
2024
revised:
10
04
2024
accepted:
02
05
2024
medline:
8
7
2024
pubmed:
8
7
2024
entrez:
8
7
2024
Statut:
epublish
Résumé
Angiotensin receptor neprilysin inhibitor is the standard of care for systolic heart failure in adults. In addition, its use in adults with failing systemic right ventricles and diastolic heart failure is promising. This study reports our experience with this drug for protein-losing enteropathy secondary to Fontan failure in pediatrics.
Identifiants
pubmed: 38973815
doi: 10.1016/j.jaccas.2024.102395
pii: S2666-0849(24)00188-8
pmc: PMC11225506
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
102395Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.